128 Participants Needed

Social Reward Psychotherapy for Suicidal Thoughts

NS
Overseen ByNili Solomonov, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Weill Medical College of Cornell University
Must be taking: Antidepressants
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This trial tests a new talk therapy called Engage & Connect, aimed at middle-aged and older adults who feel socially isolated. The therapy encourages enjoyable social activities to help improve mood and reduce suicidal thoughts by making people feel happier and more connected.

Will I have to stop taking my current medications?

The trial requires that you either be off antidepressants or on a stable dose for 8 weeks, and you should not plan to change the dose during the study. Other psychotropic drugs are generally not allowed, except for a small dose of lorazepam.

What data supports the effectiveness of the treatment Social Reward Psychotherapy for Suicidal Thoughts?

Research shows that therapies like cognitive behavioral therapy (CBT) and problem-solving therapy (PST) can help reduce suicidal thoughts and behaviors. These therapies have been effective in improving mental health outcomes for people who have attempted suicide, suggesting that similar approaches in Social Reward Psychotherapy might also be beneficial.12345

Is Social Reward Psychotherapy for Suicidal Thoughts safe for humans?

The available research does not provide specific safety data for Social Reward Psychotherapy or its other names, but psychotherapy in general is considered safe for humans, with studies showing it can help reduce suicidal thoughts and behaviors.16789

What makes Engage & Connect Psychotherapy unique for treating suicidal thoughts?

Engage & Connect Psychotherapy is unique because it focuses on enhancing social connections and rewarding social interactions, which can improve feelings of hope and belongingness, unlike traditional therapies that primarily target psychiatric symptoms.110111213

Research Team

NS

Nili Solomonov, PhD

Principal Investigator

Weill Medical College of Cornell University

Eligibility Criteria

This trial is for individuals aged 50-80 with Major Depressive Disorder and suicidal thoughts, who have a certain level of cognitive function (MMSE score within normal range) and are either off antidepressants or on a stable dose. They must not be receiving other psychotherapy, have no plans to change medication doses, and cannot have severe medical conditions or other psychiatric diagnoses that could interfere with the study.

Inclusion Criteria

I've been on a stable dose of antidepressants for 8 weeks and won't change it.
I am able to understand and agree to the research and treatment plan.
I have been diagnosed with Major Depressive Disorder.
See 4 more

Exclusion Criteria

I have a neurological disorder like dementia or Parkinson's.
Intent or plan to attempt suicide in the near future
I take 0.5 mg or less of lorazepam daily, but no other psychotropic drugs.
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants are randomly assigned to 9-weekly sessions of either Engage & Connect therapy or Symptom Review and Psychoeducation

9 weeks
9 visits (virtual)

Assessment

Participants complete 4 research assessments and 3 MRI scans to evaluate brain- and behavioral changes

9 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Engage & Connect Psychotherapy
  • Symptom Review and Psychoeducation (SRP)
Trial Overview'Engage & Connect' Psychotherapy is being tested against Symptom Review and Psychoeducation (SRP) over a 9-week period to see if it improves brain functions related to positive emotions and reduces suicidality in older adults suffering from depression.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: "Engage & Connect" PsychotherapyExperimental Treatment1 Intervention
Engage \& Connect is a remotely-delivered psychotherapy, aimed to increase engagement in rewarding social activities and in turn, reduce suicidality. In Engage \& Connect, depressed middle-aged and older adults with suicidal ideation work with a therapist to develop "action plans" to pursue rewarding social activities of their choice.
Group II: Symptom Review and Psychoeducation (SRP)Active Control1 Intervention
In this intervention, the therapist will review the participant's symptoms and provide literature-based clinical explanations and clarifications about the symptoms, the course, and the causes of depression and aging processes. In SRP, the therapist reviews the depressed individual's symptoms, and level of information on depression, identifies misconceptions, and guides selection of educational material which could benefit the patient.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Weill Medical College of Cornell University

Lead Sponsor

Trials
1,103
Recruited
1,157,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Findings from Research

Cognitive behavioral therapy (CBT) and dialectical behavioral therapy (DBT) have been identified as effective psychotherapeutic treatments for individuals who have attempted suicide, based on recent Cochrane reviews and meta-analyses.
Despite the effectiveness of these therapies, the overall impact is small, and there are significant methodological issues in the research, indicating a need for better empirical support and wider dissemination of suicide-specific psychotherapy programs.
[Psychotherapy after a suicide attempt-current evidence and evaluation].Teismann, T., Gysin-Maillart, A.[2022]
Cognitive behavior therapy (CBT) and problem-solving therapy (PST) both led to significant improvements in various measures related to hopelessness and suicidal ideation among suicide attempters, indicating their efficacy as treatment options.
Participants receiving CBT and PST reported higher satisfaction levels compared to those receiving treatment as usual (TAU), highlighting the potential benefits of these brief therapies in managing suicidal thoughts.
Comparing cognitive behavior therapy, problem solving therapy, and treatment as usual in a high risk population.Stewart, CD., Quinn, A., Plever, S., et al.[2018]
Psychotherapeutic interventions have been shown to effectively reduce suicidal thoughts and behaviors, as evidenced by several randomized controlled trials (RCTs) that demonstrate their efficacy in preventing suicide attempts.
Despite these positive findings, the current literature has significant gaps and methodological limitations, indicating a need for more rigorous research to enhance the effectiveness of suicide prevention therapies.
Evidence-based psychotherapies for suicide prevention: future directions.Brown, GK., Jager-Hyman, S.[2022]

References

[Psychotherapy after a suicide attempt-current evidence and evaluation]. [2022]
Comparing cognitive behavior therapy, problem solving therapy, and treatment as usual in a high risk population. [2018]
Evidence-based psychotherapies for suicide prevention: future directions. [2022]
Suicide and suicidal behaviours: implications for mental health services. [2017]
Strategies in treatment of suicidality: identification of common and treatment-specific interventions in empirically supported treatment manuals. [2022]
The BEACON study: protocol for a cohort study as part of an evaluation of the effectiveness of smartphone-assisted problem-solving therapy in men who present with intentional self-harm to emergency departments in Ontario. [2023]
Effect of Problem-Solving Therapy on Depressed Low-Income Homebound Older Adults' Death/Suicidal Ideation and Hopelessness. [2022]
Comprehensive database and individual patient data meta-analysis of randomised controlled trials on psychotherapies reducing suicidal thoughts and behaviour: study protocol. [2021]
The Effectiveness of the Safety Planning Intervention for Adults Experiencing Suicide-Related Distress: A Systematic Review. [2022]
Suicide Models and Treatment Models Are Separate Entities. What Does It Mean for Clinical Suicide Prevention? [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
Core principles in treating suicidal patients. [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
Comparison of compensation and capitalization models when treating suicidality in young adults. [2009]
13.United Statespubmed.ncbi.nlm.nih.gov
Development and pilot study of a suicide prevention intervention delivered by peer support specialists. [2022]